Multi-organ Transplantation

The multi-organ transplant department primarily admits end-stage multi-organ failure patients requiring two or more organ transplants simultaneously, such as those eligible for combined liver-kidney, heart-lung, or liver-intestine transplants. The treatment process includes multidisciplinary evaluation, determination of transplant indications and contraindications, perioperative management, immunosuppression regimen development, and long-term follow-up. The treatment goals are to improve survival, restore organ function, and enhance quality of life. Due to the complexity of the surgery and the high intensity of immunosuppression, the risks of infection, rejection, thrombosis, biliary or vascular complications, renal impairment, and metabolic complications require continuous monitoring. The benefits of transplantation may be limited if there is active infection, uncontrolled malignancy, severe cardiopulmonary reserve deficiency, or poor adherence. Long-term management emphasizes vaccination, cancer screening, bone health management, control of cardiovascular risk factors, and psychosocial support.